Compass Therapeutics, Inc. (CMPX) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Compass Therapeutics, Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -12.74x | -4.03x | -4.66x | -13.49x | -2.43x | -12.75x |
| P/B Ratio | 4.30x | 1.59x | 1.33x | 2.91x | 1.42x | -3.73x |
| P/S Ratio | 0.00x | 233.89x | 0.00x | 0.00x | 0.00x | 0.00x |
| Profitability | ||||||
| Gross Margin | 0.0% | 100.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Operating Margin | 0.0% | -6661.8% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net Margin | 0.0% | -5808.8% | 0.0% | 0.0% | 0.0% | 0.0% |
| EBITDA Margin | 0.0% | -6455.5% | 0.0% | 0.0% | 0.0% | 0.0% |
| Liquidity | ||||||
| Current Ratio | 15.02x | 14.96x | 19.73x | 12.05x | 13.84x | 2.67x |
| Quick Ratio | 15.02x | 14.96x | 19.73x | 12.05x | 13.84x | 2.67x |
| Leverage | ||||||
| Debt/Equity | 0.05x | 0.05x | 0.01x | 0.02x | 0.03x | -0.13x |
YoY = year-over-year change. Source: FMP..